George F. Tidmarsh

Learn More
PURPOSE This multicenter phase II study evaluated the efficacy, dosimetry methodology, and safety of iodine-131 tositumomab in patients with chemotherapy-relapsed/refractory low-grade or transformed(More)
AIM In this study, the fluorodeoxyglucose (FDG) uptake was prospectively investigated in tumors as well as the normal organs over 8 h in patients with non small cell lung carcinoma (NSCLC). The(More)
8048 Background: At the time of regulatory approval of 90-Y ibritumomab tiuxetan (Zevalin Z), 3 countries (USA, Switzerland, Japan) required labeling specifying that a 111-In imaging scan be(More)